A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.

NCT00454246 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

111

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision unrelated to safety or efficacy

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta
DRUG: epoetin alfa
DRUG: darbepoetin alfa

Sponsor

Hoffmann-La Roche